Advent International $3.8 billion acquisition of inVentiv Health

1/8/2016
Private acquisition

$ 3.8 billion

Completed

1/8/2016


Overview:

  • Private equity firm Advent International has acquired inVentiv Health in a $3.8 billion deal.
  • Advent joins fellow private equity firm Thomas H Lee Partners as equal equity owners of inVentiv.
  • The transaction is expected to close Q4, 2016.
  • Kirkland & Ellis (Douglas Ryder, Jeffrey Seifman, Joshua Soszynski, Jay Ptasek, Nicholas Schwartz, Ross Leff) advised Advent.
  • Weil Gotshal & Manges (Michael Aiello, Sachin Kohli) advised inVentiv and Thomas H Lee Partners.

Kurt Stumpo - Journalist - North America and the Caribbean

Jurisdiction:

United States

Deal type:

Private acquisition

Practice areas:

Private equity
M&A

Governing law:

United States

Industry sector:

Pharmaceuticals and life sciences


Firms:

Party: Advent International (Acquirer)

Lawyer: Douglas Ryder


Party: inVentiv (Target)

Lawyer: Michael Aiello